THERAPEUTIC RESEARCH IN REVIEW.
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000959:Antihypertensive Agents; D002614:Chelating Agents; D019411:Clinical Laboratory Techniques; D003545:Cysteine; D003975:Diazepam; D004304:Dosage Forms; D004345:Drug Industry; D004358:Drug Therapy; D006527:Hepatolenticular Degeneration; D006561:Herpes Simplex; D006801:Humans; D006993:Hypnotics and Sedatives; D007065:Idoxuridine; D007093:Imidazoles; D008458:Measles Vaccine; D008750:Methyldopa; D008996:Monoamine Oxidase Inhibitors; D009640:Norethindrone; D010276:Parasympatholytics; D010406:Penicillins; D012106:Research; D036302:Therapeutic Human Experimentation; D014149:Tranquilizing Agents; D014750:Vincristine
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000959:Antihypertensive Agents; D002614:Chelating Agents; D004304:Dosage Forms; D006993:Hypnotics and Sedatives; D007093:Imidazoles; D008458:Measles Vaccine; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D010406:Penicillins; D014149:Tranquilizing Agents; D008750:Methyldopa; D014750:Vincristine; D003545:Cysteine; D007065:Idoxuridine; D003975:Diazepam; D009640:Norethindrone
ANTIBIOTICS; ANTIHYPERTENSIVE AGENTS; CHELATING AGENTS; CYSTEINE; DIAGNOSIS, LABORATORY; DIAZEPAM; DOSAGE FORMS; DRUG INDUSTRY; DRUG THERAPY; HEPATOLENTICULAR DEGENERATION; HERPES SIMPLEX; HYPNOTICS AND SEDATIVES; IDOXURIDINE; IMIDAZOLES; MEASLES VACCINE; METHYLDOPA; MONOAMINE OXIDASE INHIBITORS; NORETHINDRONE; PARASYMPATHOLYTICS; PENICILLIN; RESEARCH; TRANQUILIZING AGENTS; VINCRISTINE